Skin and Soft Tissue Infections in Pregnancy

  • Chapter
  • First Online:
Infections and Pregnancy

Abstract

Skin and soft tissue infections (SSTIs) are an important cause of morbidity and mortality in pregnant and postpartum women. SSTIs in pregnancy and puerperium range from mild to a moderate variety of infections like cellulitis, simple abscess, mastitis to severe degrees of fulminant infections like necrotizing fasciitis. Most SSTIs in puerperium originate at the breast, infected wound site following a surgical procedure, or traumatic vaginal deliveries. Mastitis and breast abscess represent an important category of SSTIs in the postpartum period associated with high morbidity; also affecting the neonatal well-being resulting from discontinuation of breastfeeding. SSTIs like necrotizing fasciitis are a rare but potential source of life-threatening complications in pregnant and postpartum women with high maternal mortality. Dominant organisms that are isolated in most cases of SSTIs are Gram-positive bacteria such as Staphylococcus aureus and Streptococcus; however, polymicrobial infections with Gram-negative and anaerobic organisms are not uncommon in severe infections. Uncomplicated SSTIs are successfully managed on an outpatient basis; severe infections extending to the deeper tissues—subcutaneous tissue, fascia, or muscle require aggressive management. Early diagnosis, the institution of appropriate antibiotics, and well-timed surgical management, if required, are key to the effective management of complicated SSTI to prevent maternal morbidity and mortality. Here, we review the etiopathology, clinical features, and treatment strategies for the management of SSTIs in pregnancy and the postpartum period.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Boakes E, Woods A, Johnson N, Kadoglou N. Breast infection: a review of diagnosis and management practices. Eur J Breast Health. 2018;14(3):136–43.

    PubMed  PubMed Central  Google Scholar 

  2. Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti-Infect Ther. 2014;12(7):753–62.

    Article  CAS  Google Scholar 

  3. Rizzo M, Gabram S, Staley C, Peng L, Frisch A, Jurado M, et al. Management of breast abscesses in nonlactating women. Am Surg. 2010;76(3):292–5.

    Article  Google Scholar 

  4. Scott-Conner CE, Schorr SJ. The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg. 1995;170(4):401–5.

    Article  CAS  Google Scholar 

  5. Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev. 2013;2:CD005458.

    Google Scholar 

  6. Amir LH. Academy of breastfeeding medicine protocol C. ABM clinical protocol #4: mastitis, revised March 2014. Breastfeed Med. 2014;9(5):239–43.

    Article  Google Scholar 

  7. Bharat A, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA. Predictors of primary breast abscesses and recurrence. World J Surg. 2009;33(12):2582–6.

    Article  Google Scholar 

  8. Givens ML, Luszczak M. Breast disorders: a review for emergency physicians. J Emerg Med. 2002;22(1):59–65.

    Article  Google Scholar 

  9. Moazzez A, Kelso RL, Towfigh S, Sohn H, Berne TV, Mason RJ. Breast abscess bacteriologic features in the era of community-acquired methicillin-resistant Staphylococcus aureus epidemics. Arch Surg. 2007;142(9):881–4.

    Article  Google Scholar 

  10. Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). 2010;89(4):217–26.

    Article  Google Scholar 

  11. Bhumbra NA, McCullough SG. Skin and subcutaneous infections. Prim Care. 2003;30(1):1–24.

    Article  Google Scholar 

  12. Kihiczak GG, Schwartz RA, Kapila R. Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol. 2006;20(4):365–9.

    Article  CAS  Google Scholar 

  13. Nissman KW, Nissman DB, Leighton BL, Varaday SS, Lockhart EM. Necrotizing fasciitis after cesarean delivery. Anesthesiology. 2011;115(6):1301.

    Article  Google Scholar 

  14. Poehlmann S, Varaklis K. Necrotizing fasciitis after delayed secondary wound closure and cesarean delivery. Obstet Gynecol. 1997;90(4 Pt 2):704–5.

    Article  CAS  Google Scholar 

  15. Goepfert AR, Guinn DA, Andrews WW, Hauth JC. Necrotizing fasciitis after cesarean delivery. Obstet Gynecol. 1997;89(3):409–12.

    Article  CAS  Google Scholar 

  16. Gallup DG, Freedman MA, Meguiar RV, Freedman SN, Nolan TE. Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency. Am J Obstet Gynecol. 2002;187(2):305–10. discussion 10-1

    Article  Google Scholar 

  17. Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36.

    Article  Google Scholar 

  18. Huang KF, Hung MH, Lin YS, Lu CL, Liu C, Chen CC, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71(2):467–73. discussion 73

    PubMed  Google Scholar 

  19. Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75(4):249–57.

    Article  CAS  Google Scholar 

  20. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect. 2009;58(4):266–72.

    Article  Google Scholar 

  21. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.

    Article  Google Scholar 

  22. Schorge JO, Granter SR, Lerner LH, Feldman S. Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlation. J Reprod Med. 1998;43(7):586–90.

    CAS  PubMed  Google Scholar 

  23. Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg. 1998;64(5):397–400. discussion-1

    CAS  PubMed  Google Scholar 

  24. Brown DR, Davis NL, Lepawsky M, Cunningham J, Kortbeek J. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167(5):485–9.

    Article  CAS  Google Scholar 

  25. Hajhosseini B, Kuehlmann BA, Bonham CA, Kamperman KJ, Gurtner GC. Hyperbaric oxygen therapy: descriptive review of the technology and current application in chronic wounds. Plast Reconstr Surg Glob Open. 2020;8(9):e 3136.

    Article  Google Scholar 

  26. Hedetoft M, Madsen MB, Madsen LB, Hyldegaard O. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort study. BMJ Open. 2020;10(10):e041302.

    Article  Google Scholar 

  27. Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1:CD007937.

    PubMed  Google Scholar 

  28. Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, et al. Plasma from patients with severe invasive group a streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996;156(8):3057–64.

    CAS  PubMed  Google Scholar 

  29. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28(4):800–7.

    Article  CAS  Google Scholar 

  30. Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis. 2014;59(6):851–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Choudhary, D., Garg, P.K. (2022). Skin and Soft Tissue Infections in Pregnancy. In: Mehta, S., Grover, A. (eds) Infections and Pregnancy. Springer, Singapore. https://doi.org/10.1007/978-981-16-7865-3_35

Download citation

  • DOI: https://doi.org/10.1007/978-981-16-7865-3_35

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-16-7864-6

  • Online ISBN: 978-981-16-7865-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation